<?xml version="1.0" encoding="UTF-8"?>
<p>Tocilizumab is a humanized anti-IL-6-receptor (IL-6R) monoclonal antibody that inhibits IL-6 signaling and is used as a treatment in rheumatoid arthritis [
 <xref rid="B79" ref-type="bibr">79</xref>]. IL-6 is one of the most important cytokines involved in COVID-19-induced cytokine storms. Tocilizumab (TCZ) has been used to treat COVID-19 in China and Italy. TCZ was recommended for COVID-19 patients to prevent or treat cytokine storms and could reduce the mortality of COVID-19 [
 <xref rid="B80" ref-type="bibr">80</xref>].
</p>
